Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Rafati

Showing results (51-60 of 136) with videos related to

Pageof 14
Sort By:
Plos One|July 15, 2020
Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilmNeda Moazzezy, Mohammad Reza Asadi Karam, Sima Rafati, et al.
Plos Neglected Tropical Diseases|January 4, 2020
Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c miceElaheh Davarpanah, Negar Seyed, Fariborz Bahrami, et al.
The Indian Journal of Medical Research|January 22, 2010
Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patientsAzam Bolhassani, Farnaz Zahedifard, Yasaman Taslimi, et al.
Immunology Letters|October 23, 2012
Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice modelAmin Daemi, Azam Bolhassani, Sima Rafati, et al.
Vaccine|June 12, 2002
Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activationSima Rafati, Amina Kariminia, Shiva Seyde-Eslami, et al.
International Journal of Medical Microbiology : IJMM|April 11, 2017
Protein/Protein, DNA/DNA and DNA/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB/c MiceMaryam Golshani, Sima Rafati, Mehdi Nejati-Moheimani, et al.
The Korean Journal of Parasitology|September 2, 2015
In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type ParasiteSomayeh Sadeghi, Negar Seyed, Mohammad-Hossein Etemadzadeh, et al.
Jundishapur Journal of Microbiology|December 9, 2014
In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer ProteinFatemeh Fotouhi, Behrokh Farahmand, Behnaz Heidarchi, et al.
Experimental Parasitology|February 13, 2021
Evaluation of protection induced by in vitro maturated BMDCs presenting CD8<sup>+</sup> T cell stimulating peptides after a heterologous vaccination regimen in BALB/c model against Leishmania majorAtefeh Sadeghi Shermeh, Farnaz Zahedifard, Sima Habibzadeh, et al.
Vaccine|September 23, 2008
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individualsNaghmeh Khoshgoo, Farnaz Zahedifard, Hiva Azizi, et al.
Pageof 14

Showing results (51-60 of 136) with videos related to

Sort By:
Pageof 14
Plos One|July 15, 2020
Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilmNeda Moazzezy, Mohammad Reza Asadi Karam, Sima Rafati, et al.
Plos Neglected Tropical Diseases|January 4, 2020
Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c miceElaheh Davarpanah, Negar Seyed, Fariborz Bahrami, et al.
The Indian Journal of Medical Research|January 22, 2010
Antibody detection against HPV16 E7 & GP96 fragments as biomarkers in cervical cancer patientsAzam Bolhassani, Farnaz Zahedifard, Yasaman Taslimi, et al.
Immunology Letters|October 23, 2012
Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice modelAmin Daemi, Azam Bolhassani, Sima Rafati, et al.
Vaccine|June 12, 2002
Recombinant cysteine proteinases-based vaccines against Leishmania major in BALB/c mice: the partial protection relies on interferon gamma producing CD8(+) T lymphocyte activationSima Rafati, Amina Kariminia, Shiva Seyde-Eslami, et al.
International Journal of Medical Microbiology : IJMM|April 11, 2017
Protein/Protein, DNA/DNA and DNA/Protein based vaccination strategies using truncated Omp2b against Brucella infection in BALB/c MiceMaryam Golshani, Sima Rafati, Mehdi Nejati-Moheimani, et al.
The Korean Journal of Parasitology|September 2, 2015
In Vitro Infectivity Assessment by Drug Susceptibility Comparison of Recombinant Leishmania major Expressing Enhanced Green Fluorescent Protein or EGFP-Luciferase Fused Genes with Wild-Type ParasiteSomayeh Sadeghi, Negar Seyed, Mohammad-Hossein Etemadzadeh, et al.
Jundishapur Journal of Microbiology|December 9, 2014
In Vitro Evaluation of Influenza M2 and Leishmania major HSP70 (221-604) Chimer ProteinFatemeh Fotouhi, Behrokh Farahmand, Behnaz Heidarchi, et al.
Experimental Parasitology|February 13, 2021
Evaluation of protection induced by in vitro maturated BMDCs presenting CD8<sup>+</sup> T cell stimulating peptides after a heterologous vaccination regimen in BALB/c model against Leishmania majorAtefeh Sadeghi Shermeh, Farnaz Zahedifard, Sima Habibzadeh, et al.
Vaccine|September 23, 2008
Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individualsNaghmeh Khoshgoo, Farnaz Zahedifard, Hiva Azizi, et al.
Pageof 14